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OBJECTIVES: Ethnic minorities are disproportionately
impacted by prostate cancer (PCa) and are at risk for
not receiving informed decision making (IDM). We
conducted a systematic literature review on interven-
tions to improve: (1) IDM about PCa in screening-
eligible minority men, and (2) quality of life (QOL) in
minority PCa survivors.
DATA SOURCES: MeSH headings for PCa, ethnic
minorities, and interventions were searched in MED-
LINE, Cochrane Database of Systematic Reviews,
Cochrane Central Register of Controlled Trials,
CINAHL, and PsycINFO.
SUBJECT ELIGIBILITY CRITERIA: We identified U.S.-
based, English-language articles (1985–2010) on inter-
ventions to improve PCa IDM and QOL that included
50 % or more minority patients or analyses stratified by
race/ethnicity.
STUDY APPRAISAL AND SYNTHESIS METHODS:
Articles (n=19) were evaluated and scored for quality
using a Downs and Black (DB) system. Interventions
were organized by those enhancing 1) IDM about PCa
screening and 2) improving QOL and symptom among
PCa survivors. Outcomes were reported by intervention
type (educational seminar, printed material, telephone-
based, video and web-based).
RESULTS: Fourteen studies evaluated interventions for
enhancing IDM about PCa screening and five evaluated
programs to improve outcomes for PCa survivors.
Knowledge scores were statistically significantly in-
creased in 12 of 13 screening studies that measured
knowledge, with ranges of effect varying across inter-
vention types: educational programs (13 %–48 % in-
crease), print (11 %–18 %), videotape/DVD (16 %), and
web-based (7 %–20 %). In the final screening study, an
intervention to improve decision-making about screen-
ing increased decisional self-efficacy by 9 %. Five
cognitive-behavioral interventions improved QOL
among minority men being treated for localized PCa
through enhancing problem solving and coping skills.
LIMITATIONS:Weak study designs, small sample sizes,
selection biases, and variation in follow-up intervals
across studies.
CONCLUSIONS: Educational programs were the most
effective intervention for improving knowledge among
screening-eligible minority men. Cognitive behavioral
strategies improved QOL for minority men treated for
localized PCa.
KEY WORDS: prostate cancer; interventions; informed decision making;
disparities; African American.
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INTRODUCTION
Prostate cancer (PCa) is a major cause of morbidity and
mortality for men in the United States. In 2010, an
estimated 217,730 new cases were diagnosed and over
30,000 men died of prostate cancer.1 African American
(AA) men have lower rates of early detection and increased
mortality compared to non-Hispanic whites.2 These stark
statistics led to increased PCa screening for all men with the
introduction of serum prostate specific antigen (PSA)
testing in the late 1980s. However, screening with PSA
has been controversial since its introduction, due to
uncertainty about the impact of PSA screening in reducing
mortality,3 its non-specificity for PCa, and its inability to
gauge PCa aggressiveness.4 Recommendations have shifted
from encouraging PSA screening5 to discouraging it as the
standard of care.6
Over the past 25 years, shared decision making between
patient and physician has been increasingly emphasized,
especially for PCa. In 1992, the American Cancer Society
recommended that all men ≥50 undergo PSA testing
annually.5 In contrast, in 1989, the United States Preventive
Services Task Force (USPSTF) recommended routine PCa
screening for men with a life expectancy >10 years and
encouraged patients who requested screening to be given
objective information about the benefits and harms of early
detection and treatment.7 Recently updated USPSTF guide-
lines now recommend against routine PSA screening in all
age groups, giving it a grade D recommendation, and
concluding with “moderate certainty” that the harms of PCa
screening outweigh the benefits.6 However, USPSTF guide-
Systematic review registration number N/A
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lines do not directly address racial and ethnic disparities in
PCa, possibly underestimating the lost benefits of discon-
tinuing testing in high-risk ethnic groups, specifically in AA
men.8,9 Despite these shifting guidelines, the call for
informed decision making (IDM) for all men, including
ethnic minorities, has remained a constant.10
IDM is important for minorities, such as AA men, who
are disproportionately affected by PCa. AA men are nearly
60 % more likely to be diagnosed with PCa and more than
twice as likely to die from it compared to white men.11
Physicians are less likely to discuss treatments with AA
men compared to white men,12 and cultural barriers may
prevent AA men from seeking emotional support regarding
their PCa.13 This suboptimal communication can lead to
increased decisional conflict, increased anxiety, and poorer
quality of life (QOL). Tillman has argued that reducing
racial-ethnic disparities should focus on instituting a well-
coordinated system of care that provides high quality
interventions focused on culturally-sensitive shared decision
making, defined by recognizing ethnicity and culture as a
central structure of the intervention.14 In addition, psycho-
logical interventions focusing on cancer-related stress and
QOL could help narrow the racial disparities in PCa
management.15
To better understand what is known about the manage-
ment of PCa for minorities, we conducted a systematic
review of the literature summarizing interventions to
improve informed decision making about PCa detection
among screening-eligible minorities, and QOL among
minority PCa survivors.
METHODS
We followed the guidelines of the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
statement.16
Initial Search
We searched MEDLINE via Ovid using specific Medical
Subject Heading (MeSH) terms. We combined MeSH terms
referring to PCa, racial/ethnic minorities, and healthcare
disparities. The specific terms included in the search
strategy were: [(Prostatic neoplasms/prostate cancer or
prostate specific antigen or psa or digital rectal examination
or dre) AND [(Race or racial or minority or African
Americans or Hispanic Americans or Asian Americans or
Indians, North American or Continental Population Groups
or African continental ancestry group or American native
continental ancestry group or Asian continental ancestry
group or oceanic ancestry group or brazil [United States] or
Portugal [United States] or Arabs[United State, or Inuits)]
OR [(Healthcare disparities or health status disparities, or
minority health or health*adj3disparit* or underserved)]
AND [(Intervention or intervention studies or health
interventions or health knowledge)] limited to English
language, humans and adults. We conducted parallel
searches in the Cochrane Database of Systematic Reviews,
Cochrane Central Register of Controlled Trials, the Cumu-
lative Index of Nursing and Allied Health Literature
(CINAHL) and PsycInfo. We then combined search results
from all databases and removed duplicate articles.
Inclusion/Exclusion Criteria
We included studies on humans, in English language that
were conducted in the US and published between 1985 and
2010. Articles had to include at least one ethnic minority
group (overall patient population more than 50 % minority
or, if less than 50 % minority, include specific analysis by
race/ethnicity) and an IDM or QOL-affecting intervention
taking place within an identified health care setting.
Community-based interventions linked to a consistent
source of health care delivery were included. The initial
search yielded 2,815 articles (Fig. 1). In light of current
recommendations, studies that assessed only screening
behavior, without consideration of IDM or QOL, were
excluded.
Article Selection (Figure 1)
Two primary reviewers (SS, AK) independently evaluated
each article for inclusion. Disagreements in articles selected
were discussed between the reviewers, with input from a
third reviewer (WD) as necessary for adjudication. Only
articles that explicitly included interventions were selected
for further review (n=76). From these articles, abstracts
were blindly and independently reviewed by SS and AK;
full articles were reviewed in the event of disagreements.
“Pre-intervention” studies, in which interventions were
being developed or tested only for feasibility, were
excluded. Articles exclusively studying screening behavior
(e.g. changes in PSA screening rates) without inclusion of
some aspect of IDM or QOL as an outcome were removed
(n=3). Following selection (n=12), each full article was
independently evaluated by the primary reviewers. Review
of references of these articles added 7 more studies to the
total (n=19).
Quality and Bias Assessment
All papers were evaluated for methodological quality using
the Downs and Black (DB) scoring algorithm (0 to 28),
which allows assessment of articles across various study
designs.17 Methods are described in detail elsewhere.18 In
brief, DB scoring rates each study based on external
validity, bias, confounding, and power. We also added one
1069Sajid et al.: Decision Making and Ethnic Disparities in Prostate Cancer ManagementJGIM
item from the Cochrane tool for bias19 that was not
captured with the DB tool, for a total maximum modified
DB score of 29. DB score ranges were grouped for
randomized studies into the following four quality levels:
very good (≥20), good (15 to 19), fair (11 to 14) and poor
(10 or less).20 We did not assess for a risk of publication
bias.
Data Extraction and Synthesis (Tables 1, 2)
The results are organized slightly differently between the
tables and text. To prevent multiple listing of studies, the
tables are organized as follows. First, the 19 studies are
divided into screening studies (Table 1) and PCa survivor
studies (Table 2). Second, within each type of study, papers
are grouped by intervention type: 1) educational program,
2) printed-material/booklets, 3) telephone/videotape/DVD,
and 4) web-based. Some studies have multiple types of
interventions, but they are listed in the area that is the
dominant intervention. Third, the specific outcome meas-
ures (e.g.—knowledge and self-efficacy for IDM in
screening-eligible men; QOL and symptom management
self-efficacy among PCa survivors) are described in the
“outcomes” column. To complete the tables, studies are
compared based on study design, sample size, ethnicity of
population, study duration, follow-up period, content of
intervention, results, and Cochrane-modified DB quality
score.
To report the findings in a way that is most
clinically meaningful, the text is organized as follows.
First, as in the table, we discuss screening studies and
survivorship studies separately. Second, we discuss out-
comes associated with each type of study. For screening
studies, we describe knowledge about PCa and screening
self-efficacy. For survivorship studies, we report QOL
and self-efficacy about symptom management. Third, we
discuss the results, within each outcome, based on the
intervention used (e.g. educational program or printed
materials).
Finally, in order to compare results across different
intervention types for the same outcome such as “knowl-
edge”, we calculated a “percent change” value for that
outcome. That is, for studies that found statistically
significant differences in that outcome across intervention
groups, we calculated and reported a “percent change/
difference” in the relevant score. While we cannot report p-
values of significance for these percentages, they provide a
range of values that can be considered for assessing the
impact of interventions across studies for specific outcomes.
The final set of articles varied significantly in outcome
reporting, use of controls, and risk adjustment, so a meta-
analysis was not possible.
RESULTS
Overall, 14 of the 19 studies were of screening-eligible men
being evaluated for IDM (Table 1), and the remaining 5 were
on improving outcomes for PCa survivors (Table 2). The
Cochrane-modified DB scores for studies varied across
intervention types as follows: (1) educational seminar
interventions, 19.3±SD 3.5; (2) printed material/booklet
Figure 1. Flow diagram of the inclusion/exclusion of studies for review.
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interventions, 22.6±SD 1.9; (3) telephone-based interven-
tions, 21.0±SD 1.7; (4) video-tape/DVD interventions, 20.3
±SD 1.7; and (5) web-based interventions, 20.0±SD 1.4,
consistent with “good” to “very good” scores.
Interventions to Enhance Informed Decision
Making for Prostate Cancer Screening
(Table 1)
Prostate Cancer Knowledge (n=13 Across Intervention
Types). Of the 14 studies of PCa screening, 13 assessed
knowledge changes, most using same day assessments. An
additional screening study did not evaluate changes in
knowledge at all and is described in the next section.18. PCa
knowledge scores increased in 12 studies19–30 and did not
change in 1.31 Five were RCTs,24,25,27,28,31 7 were pre-/
post-test studies,19–23,29,30 and 1 a cohort study.26 Eight
assessed the effects of educational programs,20–23,25,26,30,31
2 printed materials/booklets,27,28 1 a videotape/DVD,19 and
2 web-based interventions.24,29 Overall, AA men
represented 84 % of the study population across the studies.
Educational Programs (n=8). PCa knowledge increased in
7 of these studies. Educational programs included
combinations of lectures provided by trained experts,
primarily people in the community trained by specialists,
and/or didactic seminars. Regardless of the source for the
questions asked, men were typically provided a basic
understanding of PCa risk factors, and they were
explained the risk, benefits and limitations of available
screening and treatment modalities.
Two RCTs tested educational programs. Holt et al built on
prior work with AA women (in which a spirituality-based
approach was used to encourage mammography), randomly
assigning one of two interventions at the church level, one
“spiritual” and one “non-spiritual”, then measuring change in
knowledge between baseline and immediately after.25 PCa
knowledge increased 21 % (from 71 % to 92 %) in the
spiritual arm, and increased 26 % (from 72 % to 98 %) in the
non-spiritual arm. In the second RCT, “early” and “delayed”
intervention groups received a culturally-tailored, multipart
intervention including a videotape, printed pamphlet, and
question answering session.31 The “early” intervention group
attended an educational seminar at baseline, while the
“delayed” intervention group attended the seminar at
3 months. The “early” intervention showed no difference
from the “delayed” intervention on PCa knowledge at
3 months.
The remaining studies were pre-/post-assessments or
cohort studies. Drake et al. designed an intervention based
on the Ottawa Decision Support Framework and Health
Belief Model.23 Knowledge increased on a 0-100 scale by
25.7 points (p<0.001).23 Collins et al. found that, following
a one-on-one counseling intervention, PCa knowledge
increased by 41 % from pre- to post-test, from 23 to 64 %
correct. Boehm et al. assessed the impact of an
education session with AA speakers, one of whom was
a physician and one a PCa survivor on PCa knowledge.20
Knowledge increased by 13 %, from 8.7 to 10.1 (p<
0.001). Wilkinson et al. assessed a one-hour seminar
using a 12-item questionnaire assessing knowledge of
PCa, and found that knowledge increased by 47 %, (26 %
to 73 %, p<0.0001).30 Powell et al. utilized an educa-
tional program with an outreach coordinator; an 11-item
knowledge inventory score increased from 8.7 to 10.1 (p
<0.0005), a 13 % increase.32 Carter et al assessed a 13-
module intervention taught by trained men to AA men;
knowledge was statistically-significantly higher in 13 of
17 areas, but percentage increases are not calculable.21
Printed Materials/Booklets (n=2). Taylor et al. conducted a
3-arm RCT comparing 1) a booklet intervention, 2) a
videotape intervention, and 3) control.28 The primary
outcome was PCa knowledge differences, measured using
an 11-item scale developed from the NCI Cancer Facts Sheet
on PCa testing. PCa knowledge scores in the booklet arm
increased from 7.2 to 9.2 (p<0.0001), an increase of 18 % in
the proportion correct (from 66 % to 84 %). Similarly, in the
videotape arm, knowledge scores increased relative to the
control arm from 7.2 to 8.5 (p<0.0001), an 11 %
improvement in the proportion correct (from 66 % to 77 %).
Stephens et al. used an RCT to assess a printed decision aid
for PCa screening.27 On a 24-item PCa knowledge scale,
scores for AA increased from 17.5 to 20.6 (p<0.001), an
increase of 13 % in the proportion correct (from 73 % to
86 %), with unchanged scores in the control arm (17.0 pre-test
vs. 17.5 post-test; p-value “not significant”).27
Telephone/Videotape/DVD Interventions (n=1). Barber et
al. reported results from their existing PCa Early Detection
Program surveying knowledge and attitudes about PCa before
and after the program was implemented.19 Knowledge scores
for the group increased from 4.6 to 5.8, p<0.01), a 16 %
increase in the proportion correct (from 66 % to 83 %).
Web-based Interventions (n=2). Weston et al. evaluated a
computer-assisted intervention by measuring pre-/post-test
knowledge using an 18-item questionnaire from the
National Cancer Institute (2002).29 PCa knowledge scores
increased from 11.2 to 14.8 (p<0.001), a 20 % increase in
the proportion correct (from 62 % to 82 %). Ellison et al.
conducted an RCT of a web-based decision aid and
measured knowledge with a validated 12-item PCa
knowledge test.24 PCa knowledge scores were 6.78 for the
usual care group and 7.67 for the decision aid group, a
difference of 7.4 % (p=0.0017).
Self-efficacy for Decision Making (n=3). Of the 14 studies
of PCa screening, there were 2 papers assessing changes in
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self-efficacy for decision making in addition to knowledge
changes,23,25 all using educational interventions. There was
an additional study that evaluated self-efficacy for decision
making alone.18
Educational Programs (n=2). Drake et al. created a theory-
driven “road map” educational intervention for improving
comfort, control and knowledge for PCa screening, and
assessed outcomes immediately after.23 It was assessed with
an 11-item decision self-efficacy scale, with scores ranging
from 0 to 100. The self-efficacy score increased from 84 to
93 (p=0.025), a 9 % overall increase. Holt investigated a
spirituality-based intervention (as described above) and
found that self-efficacy for IDM significantly increased
(mean=0.55 in the intervention arm versus mean=0.44 in
the control arm; p<0.05).25
Printed Materials/Booklets (n=1). Kripalani et al.
investigated the likelihood of a discussion about PCa in
screening-eligible men, 90 % of whom were AA.18
Patients were randomized to receive a patient education
handout, a “cue” handout to ask about PCa, or a generic
handout (control), and the likelihood of a discussion
with the physician was recorded. Compared with the
control group’s likelihood of a conversation (37.3 %),
the “cue” handout increased the likelihood the most
(58.0 %; OR: 2.39[1.26–4.52]), but the education
handout also significantly increased the likelihood
(50.0 %; OR: 1.92[1.01–3.65]).
Interventions to Improve Outcomes
for Prostate Cancer Survivors
Quality of Life (QOL) (n=3). The interventions designed to
improve QOL in minority cancer survivors all showed
statistically significant improvements.33–35
Educational Programs (n=2). Two studies, both by
Penedo et al., focused on Hispanic men following
treatment for localized PCa.21,22 One study captured a
racially/ethnically diverse group (34 % Hispanic, 22 % AA,
35 % white), 33 and the other was conducted in Hispanic
men only.34 In both, a 10-week Cognitive-Behavioral Stress
Management course36 was compared to a 1 day seminar
with a control condition. QOL was measured using the 27-
item Functional Assessment of Cancer Therapy-General
(FACT-G) Scale, assessing QOL across 4 domains
(physical, social/family, emotional and functional). In the
mixed ethnicity study, the intervention significantly
improved mean QOL in the intervention group (87.31±
12.41 vs. 90.48±11.27; p<0.01), but not in the control
group (89.37±14.30 vs. 88.65±13.19; p>0.10) In the
Hispanic-only study, several domains of QOL improved
including: total QOL (82.35±14.02 vs.87.22±13.21; p=
0.05); physical well-being (23.98±4.51 vs. 25.51±3.80; p=
0.002); emotional well-being (19.24±4.04 vs. 20.73±3.31;
p=0.04); and sexual functioning (5.61±6.35 vs. 7.78±6.79;
p=0.002).33
Telephone/Videotape/DVD Interventions (n=1). In a third
QOL study, Campbell et al. conducted an RCT of a telephone-
based coping skills intervention and evaluated QOL in AA
men and their partners.35 QOL was measured using the SF-36
for general QOL and a disease-specific symptom assessment,
the Expanded Prostate Cancer Index Composite (EPIC). The
intervention group scored higher than the control group on the
SF-36 on the Mental Health sub-scale (24.8 vs. 25.2; p<0.08)
but not on the Physical Health sub-scale (27.5 vs. 26.1; p=
0.34). At 6 weeks, patients reported improved QOL related to
bowel symptoms (p<0.05) and hormonal symptoms (p<0.05)
on the EPIC. However, the overall SF-36 scale showed no
significant change.
Symptom Management Self-efficacy (n=2). Mishel et al.
conducted two related RCTs assessing symptom management
in both AA and white men, focused on improving self-
efficacy for symptom management in men receiving treatment
for localized PCa using a DVD/booklet/telephone
intervention.37,38
Telephone/Videotape/DVD Interventions (n=2). The effect
of an “uncertainty management” invention on symptom
control, using weekly telephone conversations with nurses
for 8 weeks, was assessed at baseline, 3 months, and
7 months.37 A 26-item, “Uncertainty in Illness” scale
measured emotional distress in AA men with localized
PCa. In the intervention arm, they found improvement for
managing uncertainty using problem solving (8.02±1.28 vs.
8.32±1.28; p<0.05) and cognitive reframing (7.70±1.37
vs. 8.20±1.37; p<0.005) at 4 months, but no additional
improvement at 7 months. In a second study also led by
Michel, the authors used a similar uncertainty management
intervention to assess self-efficacy for PCa and treatment-
related symptoms.38 The intervention improved problem-
solving ability (p=0.05). This effect persisted at 1 month,
but disappeared at 3 months. No other differences were
found.
DISCUSSION
The majority of interventions for ethnic/racial minority
men, including both screening-eligible and treatment
populations, improved some aspect of IDM or QOL for
PCa. We draw the following conclusions from the studies:
First, all but one relevant intervention for screening-
eligible ethnic minority men increased PCa knowledge.
Second, all relevant interventions improved self-efficacy
for decision making about screening or symptom manage-
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ment. Third, educational programs showed the greatest
percentage increase in knowledge across studies. Fourth,
all culturally-sensitive psychosocial interventions in ethnic
minorities successfully improved post-PCa treatment QOL
and symptom management, at least in the short term.
However, the overall magnitude of effect of one interven-
tion compared with another was difficult to ascertain
because of differences in interventions, differences in
outcome measures, variations in patient populations and
variations in study design, study duration, and analytical
methods.
As hypothesized, shared decision making programs in
ethnic minorities significantly increased PCa knowledge,
at least in the short term. Interventions to improve
knowledge about PCa in predominantly white, low-risk
populations decrease PSA testing.39–42 It is unclear what
effect knowledge interventions have on rates of PSA
testing in minority populations. Educational materials in
multiple formats—including educational programs,
printed materials, telephone, DVD and web-based pre-
sentations—all facilitate IDM. Educational programs had
the largest increases in PCa knowledge scores compared
with printed materials/booklets, telephone/videotape/
DVD, and web-based interventions. Only one study
reported the effect of specific, competing interventions
on PCa knowledge; printed materials were shown to be
slightly more effective than videotapes for improving and
retaining PCa knowledge at 1 month.28 Studies generally
assessed changes in PCa knowledge on the same day the
intervention ended. Long term effects of interventions in
screening-eligible populations are unknown.
Only 5 studies tested interventions to improve PCa
treatments to reduce disparities. This lack of research is a
major concern, particularly with a likely future decrease in
PCa screening rates and a renewed emphasis on treatment
only for symptomatic PCa. In the studies we identified, all
culturally-sensitive cognitive behavioral interventions tar-
geting treatment-related complications in ethnic minorities
improved QOL. Most men treated for PCa survive many
years and suffer from treatment-related complications.43
Managing the disease and its treatments long-term is even
more crucial for ethnic minorities as they are less likely to
discuss treatment-related complications with their physi-
cians,44 potentially leading to poorer QOL outcomes
following treatment for PCa.33–35 In addition, ethnic
minority men, who are more likely to be in lower socio-
economic categories, typically have worse QOL outcomes
and longer recovery periods from PCa treatments. For
instance, Litwin et al. found that compared with whites,
non-whites were much less likely to return to pretreatment
level of physical (55 % vs. 90 %) and social (72 % vs.
91 %) functioning 1 year post-prostatectomy.45 In advanced
PCa, men in underserved populations had faster QOL
declines on SF-36 scores.46 Given the high prevalence of
PCa in these men, it is critical to develop interventions that
improve their QOL related to treatment.47
LIMITATIONS
Our review has several limitations. For historical reasons,
most interventions were targeted to increasing PSA screen-
ing rates, which was an accepted goal during the time of
most of these studies. However, we focused on the impact
on IDM, which remains the central tenant of PCa
management. Further, we did not assess for a risk of
publication bias. A meta-analysis of the studies was not
feasible given the lack of consistency in interventions,
variability in follow-up intervals and outcomes across
studies. Analysis of which intervention yielded the most
improvement in PCa knowledge score is hampered by use
of different knowledge scales across studies, lack of validity
of several PCa knowledge scales, variability in study
quality as assessed by Cochrane-modified DB scores,
variation in the type of PCa knowledge provided within
specific interventions, and lack of information on the effect
of individual components of multi-faceted interventions on
a specific outcome. Also, almost all of the studies assessed
these outcomes on the same day as the interventions, and it
is not clear that such knowledge would be retained after
longer periods of time.
CONCLUSIONS
Overall, despite the increased risk of high-risk PCa in
minority men, we found disappointingly few articles in the
last 25 years on interventions to reduce those disparities.
While screening for PCa has fallen out of favor, the core
management strategy for PCa remains IDM. Appropriate
interventions have consistently improved knowledge,
increased self-efficacy, and raised QOL—all core compo-
nents of IDM.48 Educational programs were the most
effective intervention for improving knowledge among
screening-eligible minority men. Cognitive behavioral
strategies improved QOL for minority men treated for
localized PCa. Going forward, it is essential that we create
a much stronger evidence base for the use of such
interventions to improve IDM across the clinical spectrum
for PCa.49
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